Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, +432

European Journal of Immunology

Laboratory ImmunologyImmunologyPathologyImmunophenotypingImmune System +16

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, +26

Journal of Clinical Investigation

First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19

Alessio Mazzoni, Nicoletta Di Lauria, Laura Maggi, +19

Journal of Clinical Investigation

Distinctive features of classic and nonclassic (<scp>T</scp>h17 derived) human <scp>T</scp>h1 cells

Laura Maggi, Veronica Santarlasci, Manuela Capone, +10

European Journal of Immunology

HistocompatibilityGeneticsT-regulatory CellImmunologyT Helper17 +18

Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab

Gaia Meoni, Veronica Ghini, Laura Maggi, +15

PLoS Pathogens

InflammationMetabolic SyndromeNovel Coronavirus DiseaseClinical SymptomsImmunology +11

Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production

Laura Maggi, Gianni Montaini, Alessio Mazzoni, +12

Journal of Allergy and Clinical Immunology

Clinical ImmunologyInflammationImmunogeneticsGroup 2Ige Production +10

Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study

Alessandra Vultaggio, Emanuele Vivarelli, Gianni Virgili, +25

The Journal of Allergy and Clinical Immunology In Practice

Demethylation of the <i>RORC2</i> and <i>IL17A</i> in Human CD4+ T Lymphocytes Defines Th17 Origin of Nonclassic Th1 Cells

Alessio Mazzoni, Veronica Santarlasci, Laura Maggi, +14

The Journal of Immunology

Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS‐CoV‐2 infection

Benedetta Peruzzi, Sara Bencini, Manuela Capone, +16

Immunology

ImmunologyPathologyImmune SystemImmunotherapyMyeloid Cells +17

Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study

Alessandro M. Vannucchi, Benedetta Sordi, A Morettini, +25

Leukemia